Published in J Biomed Biotechnol on October 09, 2011
Flagella overexpression attenuates Salmonella pathogenesis. PLoS One (2012) 0.98
Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella. Virulence (2012) 0.96
Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector. PLoS One (2012) 0.81
Viral and bacterial infections associated with camel (Camelus dromedarius) calf diarrhea in North Province, Saudi Arabia. Saudi J Biol Sci (2011) 0.80
Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine development. Clin Vaccine Immunol (2012) 0.80
Role of overexpressed CFA/I fimbriae in bacterial swimming. Phys Biol (2012) 0.79
Attenuating gene expression (AGE) for vaccine development. Virulence (2013) 0.78
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets. Infect Immun (1972) 11.29
Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains. Microbiol Rev (1982) 8.90
The establishment of K99, a thermolabile, transmissible escherichia coli K antigen, previously called "Kco", possessed by calf and lamb enteropathogenic strains. Acta Pathol Microbiol Scand B (1975) 5.85
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Occurrence of K99 antigen on Escherichia coli isolated from pigs and colonization of pig ileum by K99+ enterotoxigenic E. coli from calves and pigs. Infect Immun (1977) 3.48
Development in motion: helper T cells at work. Cell (2007) 3.24
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect (2009) 2.39
Occurrence and characteristics of enterotoxigenic Escherichia coli isolated from calves with diarrhea. Infect Immun (1976) 2.17
Enterotoxigenic Escherichia coli (ETEC) in farm animals. Vet Res (1999) 2.15
A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol (2010) 2.08
A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun (2010) 1.92
Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. J Health Popul Nutr (2004) 1.75
Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea. Vaccine (1989) 1.73
Epidemic diarrhea due to enterotoxigenic Escherichia coli. Clin Infect Dis (2005) 1.63
Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology (1984) 1.38
Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett (2006) 1.35
Vaccines for enterotoxigenic Escherichia coli: current status. Curr Opin Gastroenterol (2005) 1.35
Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis (1998) 1.34
Colonization factors of diarrheagenic E. coli and their intestinal receptors. J Ind Microbiol (1995) 1.32
Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun (1999) 1.30
Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol (2007) 1.29
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun (2002) 1.20
Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli. J Bacteriol (1989) 1.19
Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect Immun (1990) 1.19
Recent advances in mucosal vaccines and adjuvants. Curr Opin Immunol (2002) 1.17
Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR. Infect Immun (1995) 1.14
Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci. Clin Microbiol Infect (2004) 1.14
Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes. FEMS Microbiol Immunol (1988) 1.12
Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species. J Clin Microbiol (2010) 1.12
Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun (2010) 1.10
Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun (1998) 1.05
Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters. Vaccine (2000) 1.03
Humanized mice are susceptible to Salmonella typhi infection. Cell Mol Immunol (2010) 1.02
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide). Vaccine (1993) 1.01
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine (2003) 0.99
Passive immunity in calf diarrhea: vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus. Infect Immun (1982) 0.99
Impaired mucosal immunity in L-selectin-deficient mice orally immunized with a Salmonella vaccine vector. J Immunol (2001) 0.94
Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor. Infect Immun (2005) 0.93
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother (2010) 0.93
Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90
New insights and directions in travelers' diarrhea. Gastroenterol Clin North Am (2006) 0.83
Immunogenicity and protective efficacy of orally or intranasally administered recombinant Lactobacillus casei expressing ETEC K99. Vaccine (2009) 0.82
Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein. Appl Environ Microbiol (2009) 0.82
Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin. Vaccine (2003) 0.81
Bactericidal activity of serum for Klebsiella rhinoscleromatis: studies on serum from a patient with rhinoscleroma and sera deficient in antibody or complement. J Med Microbiol (1982) 0.81
Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb. Appl Microbiol Biotechnol (2010) 0.79
Oral ingestion of egg yolk immunoglobulin from hens immunized with an enterotoxigenic Escherichia coli strain prevents diarrhea in rabbits challenged with the same strain. Infect Immun (1992) 0.77
Inhibition of adhesion of enterotoxigenic Escherichia coli K88 by soya bean tempe. Lett Appl Microbiol (2002) 0.77
Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis. Science (2009) 2.48
Analyses of soft tissue from Tyrannosaurus rex suggest the presence of protein. Science (2007) 1.76
IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol (2010) 1.53
Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. J Leukoc Biol (2011) 1.48
Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J Immunol (2007) 1.30
Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol (2007) 1.29
Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge. Infect Immun (2006) 1.21
Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature. PLoS One (2013) 1.19
Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect Immun (2005) 1.18
Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. J Clin Microbiol (2010) 1.16
A live diarrheal vaccine imprints a Th2 cell bias and acts as an anti-inflammatory vaccine. J Immunol (2005) 1.06
Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters. Clin Chim Acta (2009) 1.05
IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J Immunol (2008) 1.04
Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J Immunol (2008) 1.01
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology (2008) 1.00
Nanoparticles to increase adhesive properties of biologically secreted materials for surface affixing. J Biomed Nanotechnol (2009) 1.00
Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis. J Immunol (2011) 0.99
Flagella overexpression attenuates Salmonella pathogenesis. PLoS One (2012) 0.98
HEPES-stabilized encapsulation of Salmonella typhimurium. Langmuir (2007) 0.97
Downregulation of multiple CDK inhibitor ICK/KRP genes upregulates the E2F pathway and increases cell proliferation, and organ and seed sizes in Arabidopsis. Plant J (2013) 0.97
Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol (2008) 0.97
M cell DNA vaccination for CTL immunity to HIV. J Immunol (2003) 0.96
Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella. Virulence (2012) 0.96
A novel neurotoxoid vaccine prevents mucosal botulism. J Immunol (2005) 0.95
Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses. Infect Immun (2011) 0.94
Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor. Infect Immun (2005) 0.93
Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections. PLoS Pathog (2012) 0.93
Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean. Planta (2004) 0.92
A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun (2008) 0.92
Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Eur J Immunol (2010) 0.91
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. J Immunol (2006) 0.91
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits. PLoS One (2011) 0.91
Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections. PLoS One (2011) 0.91
Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Infect Immun (2013) 0.91
Quantification of malonylcarnitine in dried blood spots by use of MS/MS varies by stable isotope internal standard composition. Clin Chim Acta (2008) 0.90
Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine (2005) 0.90
Progress in Brucella vaccine development. Front Biol (Beijing) (2013) 0.90
Absence of L-selectin delays mucosal B cell responses in nonintestinal effector tissues. J Immunol (2002) 0.90
Modification of surface properties of a poly(dimethylsiloxane)-based elastomer, RTV11, upon exposure to seawater. Langmuir (2006) 0.89
Antibody selection for immobilizing living bacteria. Anal Chem (2009) 0.89
Challenges for physical characterization of silver nanoparticles under pristine and environmentally relevant conditions. J Environ Monit (2011) 0.89
Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection. Infect Immun (2007) 0.88
Efficient immobilization and patterning of live bacterial cells. Langmuir (2008) 0.88
Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine (2006) 0.88
DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate. Vaccine (2009) 0.88
Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health A (2003) 0.87
SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite. Toxicol Lett (2010) 0.87
Porphyrin as an ideal biomarker in the search for extraterrestrial life. Astrobiology (2007) 0.86
Nanoscale structural and mechanical properties of nontypeable Haemophilus influenzae biofilms. J Bacteriol (2009) 0.86
Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Transfusion (2013) 0.85
IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE). PLoS One (2010) 0.85
Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population. DNA Cell Biol (2013) 0.85
Mucosal lymphatic-derived gammadelta T cells respond early to experimental Salmonella enterocolitis by increasing expression of IL-2R alpha. Cell Immunol (2007) 0.85
A live bioprobe for studying diatom-surface interactions. Biophys J (2004) 0.84
Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain. Neuron Glia Biol (2012) 0.84
Bacteria survive multiple puncturings of their cell walls. Langmuir (2009) 0.84
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. J Autoimmun (2011) 0.83
Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27. J Immunol (2013) 0.83
Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues. Eur J Immunol (2002) 0.83
IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis. J Leukoc Biol (2012) 0.83
From migraine to chronic daily headache: the biological basis of headache transformation. Headache (2007) 0.82
Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell Physiol Biochem (2015) 0.82
Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1. Neuron Glia Biol (2006) 0.82
A single tube modified allele-specific-PCR for rapid detection of erythromycin-resistant Mycoplasma pneumoniae in Beijing. Chin Med J (Engl) (2012) 0.82
Development of a transient CD4(+)CD8(+) T cell subset in the cervical lymph nodes following intratracheal instillation with an adenovirus vector. Cell Immunol (2002) 0.81
Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector. PLoS One (2012) 0.81
[Analysis of clinical manifestations of hospitalized children infected with seasonal influenza A virus and 2009 novel influenza A (H1N1) virus in Beijing]. Zhonghua Er Ke Za Zhi (2011) 0.80
An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague. Vaccine (2008) 0.80